重复低强度红光(RLRL)照射辅助儿童青少年近视治疗的研究应用已在国内多地开展,初步临床研究结果显示,RLRL眼部照射能够抑制儿童青少年近视的快速增长,但由于目前尚无相关的统一标准,导致不规范应用的现象时有发生,也增加了不良反应的潜在风险。因此有关专家基于当前的循证证据及结合实践经验,并广泛征求意见,从RLRL照射防控近视基本原理、适用对象、方法及剂量、检查项目及照射频次、设备选择及使用功率、不良反应、终止治疗、与其他方法联合应用问题的建议等8个方面制定《重复低强度红光照射辅助治疗儿童青少年近视专家共识(2022)》,为规范RLRL照射在儿童青少年近视防控中的应用提供指导意见。
Repeated low-level red-light (RLRL) therapy has been adopted into research and practice on childhood myopia control nationwide.Preliminary clinical evidence showed that RLRL has some effect on slowing myopia progression.However, sub-optimal applications could become a challenge, including increase in risk of potential adverse reactions, due to a lack of consolidated standards.Accordingly, based on current evidence and expert consensus, presented as eight aspects including basic mechanism, eligibility, procedures and dosage, clinical examinations, device and power specification, adverse reactions, use termination and combined use with other treatments, this Expert consensus on repeated low-level red-light therapy as an alternative treatment of childhood myopia (2022) was developed, with an aim to standardize this new clinical procedure.
http://www.guidelines-registry.cn/, IPGRP-2022CN323
《重复低强度红光照射辅助治疗儿童青少年近视专家共识(2022)》专家组. 重复低强度红光照射辅助治疗儿童青少年近视专家共识(2022)[J]. 中华实验眼科杂志,2022,40(07):599-603.
DOI:10.3760/cma.j.cn115989-20220616-00279版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。
http://www.guidelines-registry.cn/,IPGRP-2022CN323

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。